0000893750-14-000018.txt : 20140214 0000893750-14-000018.hdr.sgml : 20140214 20140214144311 ACCESSION NUMBER: 0000893750-14-000018 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140214 DATE AS OF CHANGE: 20140214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001484478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271197863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85529 FILM NUMBER: 14615016 BUSINESS ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-456-7800 MAIL ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: PPD Therapeutics, Inc. DATE OF NAME CHANGE: 20100218 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Invus Public Equities, L.P. CENTRAL INDEX KEY: 0001340097 IRS NUMBER: 980420215 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O THE INVUS GROUP, LLC STREET 2: 750 LEXINGTON AVENUE, 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-317-7520 MAIL ADDRESS: STREET 1: C/O THE INVUS GROUP, LLC STREET 2: 750 LEXINGTON AVENUE, 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Invus Public Equities, LP DATE OF NAME CHANGE: 20050928 SC 13G/A 1 sch13ga.htm FURIEX PHARMACEUTICALS, INC. NO. 5 sch13ga.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
 
 
 
Under the Securities Exchange Act of 1934
 
(Amendment No. 5)*


FURIEX PHARMACEUTICALS, INC.
(Name of Issuer)


Common Stock, par value $0.001 per share
(Title of Class of Securities)


36106P101
(CUSIP Number)


December 31, 2013
(Date of Event which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[   ]  Rule 13d-1(b)
[X]  Rule 13d-1(c)
[   ]  Rule 13d-1(d)
 
*  The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
Page 1
 

 

 
 
 
 

CUSIP No. 36106P101
13G
  
   
1.
Name of Reporting Persons:  Invus Public Equities, L.P.
 
2
Check the Appropriate Box if a Member of a Group
(a)  [  ]
   
(b)  [  ]
3.
SEC Use Only
 
4.
Citizenship or Place of Organization:  Bermuda
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
6.
Shared Voting Power:  870,842
 
7.
Sole Dispositive Power:  0
 
8.
Shared Dispositive Power:  870,842
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  870,842
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[  ]
 
11.
Percent of Class Represented by Amount in Row (9):  8.4%
 
12.
Type of Reporting Person (See Instructions):  PN
 

Page 2
 



 
 
 
 


CUSIP No. 36106P101
13G
  
   
1.
Name of Reporting Persons:  Invus Public Equities Advisors, LLC
 
2
Check the Appropriate Box if a Member of a Group
(a)  [  ]
   
(b)  [  ]
3.
SEC Use Only
 
4.
Citizenship or Place of Organization:  Delaware
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
6.
Shared Voting Power:  870,842
 
7.
Sole Dispositive Power:  0
 
8.
Shared Dispositive Power:  870,842
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  870,842
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[  ]
 
11.
Percent of Class Represented by Amount in Row (9):  8.4%
 
12.
Type of Reporting Person (See Instructions):  OO
 


Page 3
 



 
 
 
 

CUSIP No. 36106P101
13G
  
   
1.
Name of Reporting Persons:  Artal International S.C.A.
 
2
Check the Appropriate Box if a Member of a Group
(a)  [  ]
   
(b)  [  ]
3.
SEC Use Only
 
4.
Citizenship or Place of Organization:  Luxembourg
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
6.
Shared Voting Power:  870,842
 
7.
Sole Dispositive Power:  0
 
8.
Shared Dispositive Power:  870,842
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  870,842
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[  ]
 
11.
Percent of Class Represented by Amount in Row (9):  8.4%
 
12.
Type of Reporting Person (See Instructions):  OO
 

Page 4
 



 
 
 
 

CUSIP No. 36106P101
13G
  
   
1.
Name of Reporting Persons:  Artal International Management S.A.
 
2
Check the Appropriate Box if a Member of a Group
(a)  [  ]
   
(b)  [  ]
3.
SEC Use Only
 
4.
Citizenship or Place of Organization:  Luxembourg
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
6.
Shared Voting Power:  870,842
 
7.
Sole Dispositive Power:  0
 
8.
Shared Dispositive Power:  870,842
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  870,842
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[  ]
  
11.
Percent of Class Represented by Amount in Row (9):  8.4%
 
12.
Type of Reporting Person (See Instructions):  OO
 

Page 5
 



 
 
 
 

CUSIP No. 36106P101
13G
  
   
1.
Name of Reporting Persons:  Artal Group S.A.
 
2
Check the Appropriate Box if a Member of a Group
(a)  [  ]
   
(b)  [  ]
3.
SEC Use Only
 
4.
Citizenship or Place of Organization:  Luxembourg
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
6.
Shared Voting Power:  870,842
 
7.
Sole Dispositive Power:  0
 
8.
Shared Dispositive Power:  870,842
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  870,842
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[  ]
 
11.
Percent of Class Represented by Amount in Row (9):  8.4%
 
12.
Type of Reporting Person (See Instructions):  OO
 


Page 6
 



 
 
 
 

CUSIP No. 36106P101
13G
  
   
1.
Name of Reporting Persons:  Westend S.A.
 
2
Check the Appropriate Box if a Member of a Group
(a)  [  ]
   
(b)  [  ]
3.
SEC Use Only
 
4.
Citizenship or Place of Organization:  Luxembourg
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
6.
Shared Voting Power:  870,842
 
7.
Sole Dispositive Power:  0
 
8.
Shared Dispositive Power:  870,842
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  870,842
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[  ]
 
11.
Percent of Class Represented by Amount in Row (9):  8.4%
 
12.
Type of Reporting Person (See Instructions):  OO
 


Page 7
 



 
 
 
 

CUSIP No. 36106P101
13G
  
   
1.
Name of Reporting Persons:  Stichting Administratiekantoor Westend
 
2
Check the Appropriate Box if a Member of a Group
(a)  [  ]
   
(b)  [  ]
3.
SEC Use Only
 
4.
Citizenship or Place of Organization:  The Netherlands
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
6.
Shared Voting Power:  870,842
 
7.
Sole Dispositive Power:  0
 
8.
Shared Dispositive Power:  870,842
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  870,842
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[  ]
 
11.
Percent of Class Represented by Amount in Row (9):  8.4%
 
12.
Type of Reporting Person (See Instructions):  OO
 

Page 8
 



 
 
 
 

CUSIP No. 36106P101
13G
  
   
1.
Name of Reporting Persons:  Mr. Pascal Minne
 
2
Check the Appropriate Box if a Member of a Group
(a)  [  ]
   
(b)  [  ]
3.
SEC Use Only
 
4.
Citizenship or Place of Organization:  Belgium
 
 
NUMBER OF
SHARES
BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON WITH
5.
Sole Voting Power:  0
 
6.
Shared Voting Power:  870,842
 
7.
Sole Dispositive Power:  0
 
8.
Shared Dispositive Power:  870,842
 
9.
Aggregate Amount Beneficially Owned by Each Reporting Person:  870,842
 
10.
Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
 
[  ]
 
11.
Percent of Class Represented by Amount in Row (9):  8.4%
 
12.
Type of Reporting Person (See Instructions):  IN
 

Page 9
 




 
 
 
 

Item 1.
(a).
Name of Issuer
Furiex Pharmaceuticals, Inc. (the “Issuer”) 
 
 
(b).
Address of Issuer’s Principal Executive Offices:
3900 Paramount Parkway, Suite 150, Morrisville, NC 27560
 
Item 2(a).
Item 2(b).
Item 2(c).
Name of Person Filing
Address of Principal Business Office
Citizenship
 
(i) Invus Public Equities, L.P. (“Invus Public Equities”)
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Bermuda limited partnership
 
(ii) Invus Public Equities Advisors, LLC (“Invus PE Advisors”)
750 Lexington Avenue, 30th Floor, New York, NY 10022
Citizenship: Delaware limited liability company
 
(iii) Artal International S.C.A. (“Artal International”)
10-12 avenue Pasteur, L-2310, Luxembourg, Luxembourg
Citizenship: Luxembourg limited partnership
 
(iv) Artal International Management S.A. (“Artal International Management”)
10-12 avenue Pasteur, L-2310, Luxembourg, Luxembourg
Citizenship: Luxembourg société anonyme
 
(v) Artal Group S.A. (“Artal Group”)
10-12 avenue Pasteur, L-2310, Luxembourg, Luxembourg
Citizenship: Luxembourg société anonyme
 
(vi) Westend S.A. (“Westend”)
10-12 avenue Pasteur, L-2310, Luxembourg, Luxembourg
Citizenship: Luxembourg société anonyme
 
(vii) Stichting Administratiekantoor Westend (the “Stichting”)
De Boelelaan 7, NL-1083 HJ Amsterdam, The Netherlands
Citizenship: Netherlands foundation
 
(viii) Mr. Pascal Minne
Place Ste. Gudule, 19, B-1000, Bruxelles, Belgium
Citizenship: Belgium
 
The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.”
 
Item 2(d).
Title of Class of Securities:
 
Common Stock, par value $0.001 (the “Shares”)
 
Item 2(e).
CUSIP Number:  36106P101
 


 



 
 
 
 


Item 3.
If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
 
This Item 3 is not applicable.
 
Item 4.
Ownership.
 
 
(a)
Amount beneficially owned
 
 
As of December 31, 2013, each of the Reporting Persons may be deemed the beneficial owner of 870,842 Shares held for the account of Invus Public Equities.
 
 
(b)
Percent of class:
 
 
As of December 31, 2013, each of the Reporting Persons may be deemed the beneficial owner of approximately 8.4% of Shares outstanding. (There were 10,371,155 Shares outstanding as of October 31, 2013, according to the Issuer’s quarterly report on Form 10-Q, filed November 12, 2013.)
 
 
(c)
Number of Shares as to which the Reporting Person has:
 
   
Invus Public Equities, Invus PE Advisors, Artal International, Artal International Management, Artal Group, Westend, The Stichting and Mr. Minne:
 
   
(i)
Sole power to vote or to direct the vote:
     
0
   
(ii)
Shared power to vote or to direct the vote:
     
870,842
   
(iii)
Sole power to dispose or to direct the disposition of:
     
0
   
(iv)
Shared power to dispose or to direct the disposition of:
     
870,842
       
Item 5.
Ownership of Five Percent or Less of a Class
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  [  ]
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
This Item 6 is not applicable.
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
 
This Item 7 is not applicable.
 
Item 8.
Identification and Classification of Members of the Group.
 
This Item 8 is not applicable.
 

Page 11
 


 

 
 
 
 

Item 9.
Notice of Dissolution of Group.
 
This Item 9 is not applicable.
 
Item 10.
Certification.
 
Each of the Reporting Persons hereby makes the following certification:
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 
 



Page 12
 


 
 
 
 

SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
INVUS PUBLIC EQUITIES, L.P.
  
   
By: INVUS PUBLIC EQUITIES ADVISORS, LLC, its general partner
  
     
By:
  
/s/ Raymond Debbane
  
Name:
  
Raymond Debbane
  
Title:
  
President
  
   
INVUS PUBLIC EQUITIES ADVISORS, LLC
  
     
By:
  
/s/ Raymond Debbane
  
Name:
  
Raymond Debbane
  
Title:
  
President
  
   
ARTAL INTERNATIONAL S.C.A.
  
   
By: ARTAL INTERNATIONAL MANAGEMENT S.A., its managing partner
  
     
By:
  
/s/ Anne Goffard
  
Name:
  
Anne Goffard
  
Title:
  
Managing Director
  
 
ARTAL INTERNATIONAL MANAGEMENT S.A.
  
     
By:
  
/s/ Anne Goffard
  
Name:
  
Anne Goffard
  
Title:
  
Managing Director
  
 
ARTAL GROUP S.A.
  
     
By:
  
/s/ Anne Goffard
  
Name:
  
Anne Goffard
  
Title:
  
Authorized Person
  
   
WESTEND S.A.
  
   
By:
  
/s/ Pascal Minne
  
Name:
  
Pascal Minne
  
Title:
  
Director
  
   
STICHTING ADMINISTRATIEKANTOOR WESTEND
  
   
By:
  
/s/ Pascal Minne
  
Name:
  
Pascal Minne
  
Title:
  
Sole Member of the Board
  





Page 13
 


 
 
 
 

MR. PASCAL MINNE
  
   
/s/ Pascal Minne
  
   
Dated: February 13, 2014
  



Page 14